Renal outcome after vancomycin treatment and renal replacement therapy in patients with severe sepsis and septic shock: A retrospective study

Journal of Critical Care

Volumn 29, Issue 4, 2014, Pages 656-661

  Otto, Gordon P ^a   Sossdorf, Maik ^a   Breuel, Hannes ^a   Schlattmann, Peter ^a   Bayer, Ole ^a   Claus, Ralf A ^a   Riedemann, Niels C ^a   Busch, Martin ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Acute kidney injury; Renal outcome; Renal replacement therapy; Sepsis; Vancomycin

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SURVIVOR; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; ACUTE KIDNEY INJURY; APACHE; LENGTH OF STAY; MIDDLE AGED; PHYSIOLOGY; SEX DIFFERENCE; SHOCK, SEPTIC; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ACUTE KIDNEY INJURY; AGED; ANTI-BACTERIAL AGENTS; APACHE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SEPSIS; SEX FACTORS; SHOCK, SEPTIC; VANCOMYCIN;

EID: 84902287788     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.03.015     Document Type: Article

References (29)

1. Mayr F.B., Yende S., Angus D.C. Epidemiology of severe sepsis. Virulence 2013, 5(1).
2. Lagu T., Rothberg M.B., Shieh M.S., et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012, 40(3):754-761.
3. Vincent J.L. Acute kidney injury, acute lung injury and septic shock: how does mortality compare?. Contrib Nephrol 2011, 174:71-77.
4. Poukkanen M., Vaara S.T., Pettila V., et al. Acute kidney injury in patients with severe sepsis in Finnish intensive care units. Acta Anaesthesiol Scand 2013, 57(7):863-872.
5. Bagshaw S.M., George C., Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008, 12(2):R47.
6. Fridkin S.K., Steward C.D., Edwards J.R., et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999, 29(2):245-252.
7. Levy E.R., Swami S., Dubois S.G., et al. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010. Infect Control Hosp Epidemiol 2012, 33(4):346-353.
8. Gupta A., Biyani M., Khaira A. Vancomycin nephrotoxicity: myths and facts. Neth J Med 2011, 69(9):379-383.
9. Wunderink R.G., Niederman M.S., Kollef M.H., et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012, 54(5):621-629.
10. Farber B.F., Moellering R.C. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983, 23(1):138-141.
11. Moellering R.C. Vancomycin: a 50-year reassessment. Clin Infect Dis 2006, 42(Suppl 1):S3-S4.
12. Liu C., Bayer A., Cosgrove S.E., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52(3):e18-e55.
13. van Hal S.J., Lodise T.P., Paterson D.L. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012, 54(6):755-771.
14. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39(2):165-228.
15. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612.
16. Deresinski S. Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration matters. Clin Infect Dis 2012, 54(6):772-774.
17. Lodise T.P., Patel N., Lomaestro B.M., et al. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009, 49(4):507-514.
18. Lameire N.H., Bagga A., Cruz D., et al. Acute kidney injury: an increasing global concern. Lancet 2013, 382(9887):170-179.
19. Coca S.G., Singanamala S., Parikh C.R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012, 81(5):442-448.
20. Eckardt K.U., Coresh J., Devuyst O., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013, 382(9887):158-169.
21. Bellomo R., Cass A., Cole L., et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361(17):1627-1638.
22. Ali T., Khan I., Simpson W., et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007, 18(4):1292-1298.
23. Quenot J.P., Binquet C., Kara F., et al. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 2013, 17(2):R65.
24. Bagshaw S.M., Uchino S., Bellomo R., et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007, 2(3):431-439.
25. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8(4):R204-R212.
26. Lopez-Novoa J.M., Quiros Y., Vicente L., et al. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011, 79(1):33-45.
27. Bagshaw S.M., George C., Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007, 11(3):R68.
28. Lameire N., Van Biesen W., Vanholder R. The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol 2006, 17(4):923-925.
29. Cano E.L., Haque N.Z., Welch V.L., et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther 2012, 34(1):149-157.